News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
92 Results
Type
Article (8)
Press Release (84)
Section
Business (31)
Deals (7)
Drug Development (21)
FDA (3)
News (64)
Policy (5)
Tag
Alliances (16)
Approvals (3)
Clinical research (19)
Collaboration (1)
COVID-19 (2)
Earnings (8)
Events (9)
FDA (3)
GLP-1 (1)
Government (1)
Healthcare (1)
Infectious disease (2)
Legal (1)
Mergers & acquisitions (7)
People (7)
Phase I (5)
Phase II (8)
Phase III (6)
Regulatory (4)
Southern California (1)
United States (1)
Date
Last 365 days (7)
2024 (6)
2023 (7)
2022 (10)
2021 (2)
2020 (7)
2019 (5)
2018 (5)
2017 (5)
2016 (2)
2015 (2)
2014 (2)
2013 (6)
2012 (4)
2011 (4)
2010 (2)
Location
Asia (4)
California (1)
Europe (36)
South America (1)
Southern California (1)
92 Results for "dompe".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
News
Eurofins Discovery Extends AI-powered Integrated Drug Discovery Collaboration
October 10, 2024
·
2 min read
Business
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Jaguar Health, Inc. today announced that Massimo Radaelli, PhD, has been appointed President of Jaguar International.
April 2, 2024
·
7 min read
Business
Dompé farmaceutici Appoints Shannon K. Sullivan as Chief Commercial Officer Biotech
Dompé today announced the appointment of Shannon K. Sullivan as Chief Commercial Officer (CCO), effective immediately.
October 10, 2023
·
3 min read
From the Eye to the Brain: World’s Top Scientists Gather in Rome to Discuss Future of Neurotrophins in Eye and Brain Research
Nature Conferences has convened a meeting of leading global scientists to discuss the state of the art and future lines of research on neurotrophins.
June 11, 2024
·
7 min read
Policy
Neurotrophic Keratitis: EMA Validates The Marketing Authorisation Application For Cenegermin Eye Drops (Oxervate) Submitted By Dompe
December 12, 2016
·
5 min read
Press Releases
Neurotrophic Keratitis Market to Reach USD 248.0 Million by 2034, Impelled by Amniotic Membrane Transplantation
August 5, 2024
·
11 min read
Dompe Receives Positive CHMP Opinion In Europe For Oxervate (Cenegermin Eye Drops) For The Treatment Of Adult Patients With Moderate Or Severe Neurotrophic Keratitis
May 23, 2017
·
4 min read
Biotech Bay
Dompé: New Published Data Point to Spike Protein Interactions with Estrogen Receptors as a cause for Coagulopathy in COVID-19 Patients, Signaling Sex Effects and a Path to Improved Vaccines
Dompé farmaceutici announced new data revealing a novel function of the SARS-CoV-2 Spike protein interaction with the human Estrogen Receptor Alpha that may lead to the severe coagulopathy observed in patients with COVID-19 and a minority of subjects receiving the SARS-CoV-2 vaccine.
November 30, 2022
·
8 min read
Cenegermin Eye Drops Receive European Union Approval: The First Biotechnological Drug Resulting From Dompe Research For The Treatment Of Moderate To Severe Neurotrophic Keratitis Is Made In Italy
July 21, 2017
·
5 min read
Dompe Offers A New “Window” On The World Of Scientific Research, With The http://Www.Dompetrials.Com Website, Dedicated To Clinical Trials
December 17, 2014
·
4 min read
1 of 10
Next
